Logo image of ECOR

ELECTROCORE INC (ECOR) Stock Fundamental Analysis

NASDAQ:ECOR - US28531P2020 - Common Stock

5.62 USD
+0.54 (+10.63%)
Last: 8/22/2025, 8:04:15 PM
5.6 USD
-0.02 (-0.36%)
After Hours: 8/22/2025, 8:04:15 PM
Fundamental Rating

3

Taking everything into account, ECOR scores 3 out of 10 in our fundamental rating. ECOR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of ECOR is average, but there are quite some concerns on its profitability. ECOR shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ECOR had negative earnings in the past year.
In the past year ECOR has reported a negative cash flow from operations.
In the past 5 years ECOR always reported negative net income.
In the past 5 years ECOR always reported negative operating cash flow.
ECOR Yearly Net Income VS EBIT VS OCF VS FCFECOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

ECOR's Return On Assets of -91.02% is on the low side compared to the rest of the industry. ECOR is outperformed by 78.07% of its industry peers.
The Return On Equity of ECOR (-1190.57%) is worse than 90.37% of its industry peers.
Industry RankSector Rank
ROA -91.02%
ROE -1190.57%
ROIC N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ECOR Yearly ROA, ROE, ROICECOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

With an excellent Gross Margin value of 85.52%, ECOR belongs to the best of the industry, outperforming 95.72% of the companies in the same industry.
In the last couple of years the Gross Margin of ECOR has grown nicely.
ECOR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
ECOR Yearly Profit, Operating, Gross MarginsECOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

4

2. Health

2.1 Basic Checks

ECOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ECOR has been increased compared to 1 year ago.
The number of shares outstanding for ECOR has been increased compared to 5 years ago.
There is no outstanding debt for ECOR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ECOR Yearly Shares OutstandingECOR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ECOR Yearly Total Debt VS Total AssetsECOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ECOR has an Altman-Z score of -16.83. This is a bad value and indicates that ECOR is not financially healthy and even has some risk of bankruptcy.
ECOR has a Altman-Z score of -16.83. This is amonst the worse of the industry: ECOR underperforms 86.63% of its industry peers.
ECOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -16.83
ROIC/WACCN/A
WACC8.9%
ECOR Yearly LT Debt VS Equity VS FCFECOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 1.10 indicates that ECOR should not have too much problems paying its short term obligations.
ECOR has a Current ratio of 1.10. This is amonst the worse of the industry: ECOR underperforms 88.24% of its industry peers.
ECOR has a Quick Ratio of 1.10. This is a bad value and indicates that ECOR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.95, ECOR is doing worse than 80.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.95
ECOR Yearly Current Assets VS Current LiabilitesECOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.03% over the past year.
Looking at the last year, ECOR shows a very strong growth in Revenue. The Revenue has grown by 30.15%.
Measured over the past years, ECOR shows a very strong growth in Revenue. The Revenue has been growing by 60.15% on average per year.
EPS 1Y (TTM)26.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
Revenue 1Y (TTM)30.15%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%20.23%

3.2 Future

ECOR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.31% yearly.
ECOR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.40% yearly.
EPS Next Y-4.2%
EPS Next 2Y40.41%
EPS Next 3Y28.31%
EPS Next 5YN/A
Revenue Next Year22.37%
Revenue Next 2Y32.91%
Revenue Next 3Y32.39%
Revenue Next 5Y27.4%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ECOR Yearly Revenue VS EstimatesECOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
ECOR Yearly EPS VS EstimatesECOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ECOR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ECOR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ECOR Price Earnings VS Forward Price EarningsECOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECOR Per share dataECOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

ECOR's earnings are expected to grow with 28.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.41%
EPS Next 3Y28.31%

More info and screens

0

5. Dividend

5.1 Amount

ECOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTROCORE INC

NASDAQ:ECOR (8/22/2025, 8:04:15 PM)

After market: 5.6 -0.02 (-0.36%)

5.62

+0.54 (+10.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners18.57%
Inst Owner Change-7.92%
Ins Owners26.44%
Ins Owner Change0.63%
Market Cap42.60M
Analysts83.64
Price Target21.5 (282.56%)
Short Float %7.81%
Short Ratio3.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.74%
Min EPS beat(2)-40.66%
Max EPS beat(2)1.19%
EPS beat(4)2
Avg EPS beat(4)-14.48%
Min EPS beat(4)-40.66%
Max EPS beat(4)9.28%
EPS beat(8)6
Avg EPS beat(8)-2.43%
EPS beat(12)6
Avg EPS beat(12)-5.19%
EPS beat(16)7
Avg EPS beat(16)-4%
Revenue beat(2)1
Avg Revenue beat(2)-1.44%
Min Revenue beat(2)-3.11%
Max Revenue beat(2)0.24%
Revenue beat(4)1
Avg Revenue beat(4)-1.48%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)0.24%
Revenue beat(8)5
Avg Revenue beat(8)4.24%
Revenue beat(12)6
Avg Revenue beat(12)1.36%
Revenue beat(16)8
Avg Revenue beat(16)1.08%
PT rev (1m)0.96%
PT rev (3m)-16.35%
EPS NQ rev (1m)-56.58%
EPS NQ rev (3m)-310.33%
EPS NY rev (1m)-33.35%
EPS NY rev (3m)-34.77%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)-19.03%
Revenue NY rev (1m)1.03%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 38.27
P/tB 38.27
EV/EBITDA N/A
EPS(TTM)-1.62
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-1.01
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS3.65
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -91.02%
ROE -1190.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.52%
FCFM N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
F-Score4
Asset Turnover1.9
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.95
Altman-Z -16.83
F-Score4
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
EPS Next Y-4.2%
EPS Next 2Y40.41%
EPS Next 3Y28.31%
EPS Next 5YN/A
Revenue 1Y (TTM)30.15%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%20.23%
Revenue Next Year22.37%
Revenue Next 2Y32.91%
Revenue Next 3Y32.39%
Revenue Next 5Y27.4%
EBIT growth 1Y10.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.33%
OCF growth 3YN/A
OCF growth 5YN/A